Can propranolol or clomipramine cause stuttering or aphasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Propranolol or Clomipramine Cause Stuttering or Aphasia?

Neither propranolol nor clomipramine are documented to cause aphasia, but clomipramine has been associated with stuttering as a rare adverse effect, while propranolol has not been reported to cause stuttering.

Propranolol and Speech Disorders

Propranolol's adverse effect profile has been extensively documented in multiple clinical practice guidelines for infantile hemangiomas and other conditions. The documented adverse effects include sleep disturbances, bronchial irritation, bradycardia, hypotension, and potential CNS effects such as memory impairment and mood changes 1.

Notably, while propranolol crosses the blood-brain barrier and adult studies have shown impairments in short- and long-term memory, psychomotor function, and mood 1, there are no reports in the medical literature or FDA labeling linking propranolol to either stuttering or aphasia. The CNS effects documented are cognitive rather than speech-related.

Clomipramine and Stuttering

The evidence regarding clomipramine and stuttering presents an interesting paradox:

Clomipramine as Treatment for Stuttering

Multiple studies have actually evaluated clomipramine as a treatment for developmental stuttering. A double-blind crossover trial found clomipramine superior to desipramine for stuttering severity, with 12 of 16 subjects reporting improved fluency 2, 3. This improvement is thought to be mediated through serotonergic mechanisms.

Clomipramine as Cause of Stuttering

Despite its therapeutic use, clomipramine paradoxically appears in the literature as a potential cause of drug-induced stuttering 4, 5. A comprehensive review of the WHO global pharmacovigilance database (VigiBase) identified antidepressants, including tricyclics like clomipramine, among drugs associated with stuttering 5. The review noted that "agents known to reduce stuttering in some people may induce it in others" 5.

Mechanism

The proposed mechanisms for drug-induced stuttering involve imbalances in neurotransmitter systems, including dopaminergic, serotonergic, GABAergic, and cholinergic pathways 4, 5, 6. Clomipramine's effects on multiple neurotransmitter systems may explain why it can both treat and potentially induce stuttering in different individuals.

Clomipramine and Aphasia

The FDA labeling for clomipramine does not list aphasia as an adverse effect 7. The documented neuropsychiatric adverse effects include:

  • Confusion
  • Memory impairment
  • Difficulty concentrating
  • Delusions and hallucinations
  • Psychotic episodes
  • Hyponatremia-related cognitive symptoms

These are cognitive and psychiatric disturbances, not language production disorders like aphasia.

Clinical Implications

If a patient develops stuttering while on clomipramine:

  • Consider this a rare but documented adverse effect
  • Evaluate whether the benefit of continued treatment outweighs this side effect
  • Normal speech typically returns shortly after drug discontinuation 4
  • The stuttering may represent an idiosyncratic reaction related to individual neurotransmitter system vulnerabilities

If a patient develops speech problems on propranolol:

  • Stuttering or aphasia would be highly unusual and should prompt evaluation for alternative causes
  • Consider other CNS effects like confusion or memory impairment that might affect communication
  • Evaluate for stroke or other neurological events, particularly given propranolol's cardiovascular effects

Important caveat: The absence of aphasia reports with either medication does not definitively exclude the possibility, but it is not a recognized adverse effect in clinical practice or regulatory documentation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.